Tibet AIM Pharm. Inc. (SHE:002826)
China flag China · Delayed Price · Currency is CNY
14.93
-0.45 (-2.93%)
Nov 13, 2026, 3:04 PM CST

Tibet AIM Pharm. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
110.1892.5845.9315.3944.1442.48
Depreciation & Amortization
191921.6924.1422.723.74
Other Amortization
0.130.13-1.781.781.78
Loss (Gain) From Sale of Assets
0.230.230.04-0.03--0.03
Asset Writedown & Restructuring Costs
2.752.750.219.930.080.08
Loss (Gain) From Sale of Investments
-3.5-3.5-3.51-2.31-1.48-0.91
Provision & Write-off of Bad Debts
-1.25-1.250.67-7.026.64-1.13
Other Operating Activities
70.970.722.50.39-0.36-1.03
Change in Accounts Receivable
26.5526.55-14.57170.446.186.19
Change in Inventory
-18.74-18.7417.63-13.42-12.09-12.52
Change in Accounts Payable
8.848.84-8.53-46.7447.54-52.44
Change in Other Net Operating Assets
-1.78-1.7848.013.04-43.9219.75
Operating Cash Flow
211.57123.72111.57166.8868.45109.52
Operating Cash Flow Growth
43.60%10.89%-33.14%143.79%-37.50%7.65%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-6.94-8.5-12.24-3.18-3.2-25.2
Sale of Property, Plant & Equipment
0.170.150.140.0800.06
Cash Acquisitions
------29.45
Investment in Securities
-50-28.54-42.14--
Other Investing Activities
7.776.512.562.241.480.91
Investing Cash Flow
-49-1.8419-43-1.72-53.68

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-22.1122.81150-
Total Debt Issued
55.3922.1122.81150-
Short-Term Debt Repaid
--33.66-11-50--40
Long-Term Debt Repaid
------0.09
Lease Payments
------0.09
Total Debt Repaid
-26.77-33.66-11-50--40.09
Net Debt Issued (Repaid)
28.62-11.5511.8-3950-40.09
Issuance of Common Stock
24.5124.51----
Repurchase of Common Stock
---50.03-0.02-2.64-3.01
Common Dividends Paid
-29.01-23.84-6.04-20.28-19.77-15.27
Other Financing Activities
-59.69-----0.83
Financing Cash Flow
-35.57-10.88-44.26-59.327.59-59.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.81-0.730.24-0-0.02-0.02
Net Cash Flow
126.19110.2786.5464.5794.31-3.38

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
204.63115.2299.33163.765.2684.33
Free Cash Flow Growth
47.21%16.00%-39.32%150.86%-22.62%33.20%
Free Cash Flow Margin
28.85%18.11%15.24%24.54%7.62%11.62%
Free Cash Flow Per Share
1.110.620.540.850.340.44
Levered Free Cash Flow
175.619822.04135.6988.2912.88
Unlevered Free Cash Flow
17698.6322.32136.4388.813.41
Free Cash Flow After Leases
204.63115.2299.33163.765.2684.24

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
-----0.83
Cash Income Tax Paid
107.4898.0696.3695.3386.7786.95
Change in Working Capital
13.0413.0444.05114.62-5.0444.54